交互式CBT治疗头痛和放松训练(iCHART):交互式语音应答技术对退伍军人创伤后头痛认知行为治疗的单臂试验研究方案

Q3 Medicine Cephalalgia Reports Pub Date : 2023-01-01 DOI:10.1177/25158163231172418
Amy S Grinberg, Olivia Datre, Daniel G. Rogers, S. W. Clark, S. Takagishi, J. Ney, E. Seng, B. Fenton, J. Sico
{"title":"交互式CBT治疗头痛和放松训练(iCHART):交互式语音应答技术对退伍军人创伤后头痛认知行为治疗的单臂试验研究方案","authors":"Amy S Grinberg, Olivia Datre, Daniel G. Rogers, S. W. Clark, S. Takagishi, J. Ney, E. Seng, B. Fenton, J. Sico","doi":"10.1177/25158163231172418","DOIUrl":null,"url":null,"abstract":"Post-traumatic headache (PTH) is persistent and highly disabling. Cognitive-behavioral therapy for headache (CBT-HA) reduces headache frequency and severity and improves people’s quality of life, yet it is underutilized and inaccessible to many. Leveraging technology to deliver evidence-based psychological treatments for headache may address barriers to treatment engagement. This single-arm, single-site pilot trial aims to test the feasibility, acceptability, clinical signal, and cost of a five-session CBT-HA intervention delivered via interactive voice response technology (IVR). Participants will include 35 Veterans with PTH receiving care within VA Connecticut Healthcare System. Participants will complete an intake interview and a 9-item, 30-day electronic headache diary during a baseline run-in period. The same diary will be done again by participants immediately after treatment completion. Following the baseline assessment period, eligible participants will receive CBT-HA via IVR for 10 weeks, including an automated daily assessment of patient-reported outcomes and retrieval of biweekly tailored feedback from a study therapist. In addition, participants will access an electronic patient workbook, and study therapists will visualize patient-reported data through a secure provider dashboard. Participants will complete validated and reliable assessment measures at baseline, immediately post-treatment completion (week 10), and 1-month post-treatment completion (week 14). The primary clinical signal outcome is the change in self-reported headache days from the 30-day baseline run-in period before treatment (weeks −4 to 0) to the 30-day post-treatment completion (weeks 10–14). Paired-samples t-tests will explore changes in outcomes from baseline. All cost analyses will be exploratory and will use micro-costing techniques. Clinical Trials.gov: NCT05093556. Registered October 26, 2021.","PeriodicalId":9702,"journal":{"name":"Cephalalgia Reports","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Interactive CBT for headache and relaxation training (iCHART): Study protocol of a single-arm trial of interactive voice response technology delivery of cognitive-behavioral therapy for Veterans with post-traumatic headache\",\"authors\":\"Amy S Grinberg, Olivia Datre, Daniel G. Rogers, S. W. Clark, S. Takagishi, J. Ney, E. Seng, B. Fenton, J. Sico\",\"doi\":\"10.1177/25158163231172418\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Post-traumatic headache (PTH) is persistent and highly disabling. Cognitive-behavioral therapy for headache (CBT-HA) reduces headache frequency and severity and improves people’s quality of life, yet it is underutilized and inaccessible to many. Leveraging technology to deliver evidence-based psychological treatments for headache may address barriers to treatment engagement. This single-arm, single-site pilot trial aims to test the feasibility, acceptability, clinical signal, and cost of a five-session CBT-HA intervention delivered via interactive voice response technology (IVR). Participants will include 35 Veterans with PTH receiving care within VA Connecticut Healthcare System. Participants will complete an intake interview and a 9-item, 30-day electronic headache diary during a baseline run-in period. The same diary will be done again by participants immediately after treatment completion. Following the baseline assessment period, eligible participants will receive CBT-HA via IVR for 10 weeks, including an automated daily assessment of patient-reported outcomes and retrieval of biweekly tailored feedback from a study therapist. In addition, participants will access an electronic patient workbook, and study therapists will visualize patient-reported data through a secure provider dashboard. Participants will complete validated and reliable assessment measures at baseline, immediately post-treatment completion (week 10), and 1-month post-treatment completion (week 14). The primary clinical signal outcome is the change in self-reported headache days from the 30-day baseline run-in period before treatment (weeks −4 to 0) to the 30-day post-treatment completion (weeks 10–14). Paired-samples t-tests will explore changes in outcomes from baseline. All cost analyses will be exploratory and will use micro-costing techniques. Clinical Trials.gov: NCT05093556. Registered October 26, 2021.\",\"PeriodicalId\":9702,\"journal\":{\"name\":\"Cephalalgia Reports\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cephalalgia Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/25158163231172418\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cephalalgia Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/25158163231172418","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

创伤后头痛(PTH)是一种持续性且高度致残的疾病。头痛的认知行为疗法(CBT-HA)降低了头痛的频率和严重程度,提高了人们的生活质量,但它没有得到充分利用,许多人无法获得。利用技术为头痛提供循证心理治疗可能会解决治疗参与的障碍。这项单臂、单点试点试验旨在测试通过交互式语音响应技术(IVR)进行的五次CBT-HA干预的可行性、可接受性、临床信号和成本。参与者将包括35名PTH退伍军人,他们在弗吉尼亚州康涅狄格州医疗保健系统内接受护理。参与者将在基线磨合期内完成一次入学面试和一份9项、30天的电子头痛日记。治疗结束后,参与者将立即再次进行同样的日记。基线评估期结束后,符合条件的参与者将通过IVR接受为期10周的CBT-HA,包括对患者报告的结果进行自动每日评估,并从研究治疗师处检索每两周一次的定制反馈。此外,参与者将访问电子患者工作簿,研究治疗师将通过安全的提供者仪表板可视化患者报告的数据。参与者将在基线、治疗后立即完成(第10周)和治疗后1个月完成(第14周)时完成经验证和可靠的评估措施。主要临床信号结果是自报告头痛天数的变化,从治疗前的30天基线磨合期(第−4至0周)到治疗后的30天(第10-14周)。配对样本t检验将探索基线结果的变化。所有成本分析都将是探索性的,并将使用微观成本计算技术。临床试验.gov:NCT05093556。注册日期:2021年10月26日。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Interactive CBT for headache and relaxation training (iCHART): Study protocol of a single-arm trial of interactive voice response technology delivery of cognitive-behavioral therapy for Veterans with post-traumatic headache
Post-traumatic headache (PTH) is persistent and highly disabling. Cognitive-behavioral therapy for headache (CBT-HA) reduces headache frequency and severity and improves people’s quality of life, yet it is underutilized and inaccessible to many. Leveraging technology to deliver evidence-based psychological treatments for headache may address barriers to treatment engagement. This single-arm, single-site pilot trial aims to test the feasibility, acceptability, clinical signal, and cost of a five-session CBT-HA intervention delivered via interactive voice response technology (IVR). Participants will include 35 Veterans with PTH receiving care within VA Connecticut Healthcare System. Participants will complete an intake interview and a 9-item, 30-day electronic headache diary during a baseline run-in period. The same diary will be done again by participants immediately after treatment completion. Following the baseline assessment period, eligible participants will receive CBT-HA via IVR for 10 weeks, including an automated daily assessment of patient-reported outcomes and retrieval of biweekly tailored feedback from a study therapist. In addition, participants will access an electronic patient workbook, and study therapists will visualize patient-reported data through a secure provider dashboard. Participants will complete validated and reliable assessment measures at baseline, immediately post-treatment completion (week 10), and 1-month post-treatment completion (week 14). The primary clinical signal outcome is the change in self-reported headache days from the 30-day baseline run-in period before treatment (weeks −4 to 0) to the 30-day post-treatment completion (weeks 10–14). Paired-samples t-tests will explore changes in outcomes from baseline. All cost analyses will be exploratory and will use micro-costing techniques. Clinical Trials.gov: NCT05093556. Registered October 26, 2021.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cephalalgia Reports
Cephalalgia Reports Medicine-Neurology (clinical)
CiteScore
2.50
自引率
0.00%
发文量
17
审稿时长
9 weeks
期刊最新文献
Protocol of a cross-sectional, multicentre and multidisciplinary study describing phenotype and burden of a midfacial segment pain Paranoid psychosis after a single parenteral dose of indomethacin administered for headache diagnosis: A case and review of the literature Extended regular use of kinetic oscillation stimulation (KOS) in refractory chronic migraine: case report of a first, single-subject experience Corrigendum to “Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies” A century of bruxism research in top-ranking medical journals
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1